{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:04:51Z","timestamp":1791396291522,"version":"4.3.3"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience & Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004080","name":"Korea Drug Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004080","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jare.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:48:13Z","timestamp":1770742093000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition"],"prefix":"10.1016","author":[{"given":"Tae-Hee","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo-Young","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenivasulu","family":"Godesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changseong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areum","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inseo","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Ah","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ga Seul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Su","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Dae","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Seung","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2026.02.012_b0005","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.phrs.2017.04.003","article-title":"Targeting the unfolded protein response in cancer","volume":"120","author":"Ojha","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2026.02.012_b0010","first-page":"2277","article-title":"The role and therapeutic implication of endoplasmic reticulum stress in inflammatory cancer transformation","volume":"12","author":"Li","year":"2022","journal-title":"Am J Can Res"},{"key":"10.1016\/j.jare.2026.02.012_b0015","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ajpath.2020.01.010","article-title":"Endoplasmic reticulum stress signaling in cancer cells","volume":"190","author":"Oakes","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jare.2026.02.012_b0020","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3390\/ijms24021566","article-title":"Endoplasmic reticulum stress and cancer: could unfolded protein response be a druggable target for cancer therapy?","volume":"24","author":"Bonsignore","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.02.012_b0025","article-title":"Small-molecule endoplasmic reticulum stress inducer triggers apoptosis in cancer cells","volume":"18","author":"Ingle","year":"2023","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jare.2026.02.012_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101890","article-title":"Spirocyclic dimer SpiD7 activates the unfolded protein response to selectively inhibit growth and induce apoptosis of cancer cells","volume":"298","author":"Kour","year":"2022","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.012_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.949001","article-title":"Nanodrugs manipulating endoplasmic reticulum stress for highly effective antitumor therapy","volume":"13","author":"Xiang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2026.02.012_b0040","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.3390\/cancers14215340","article-title":"Looking into endoplasmic reticulum stress: the key to drug-resistance of multiple myeloma?","volume":"14","author":"Wang","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jare.2026.02.012_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5483\/BMBRep.2020.53.2.108","article-title":"Overcoming multidrug resistance by activating unfolded protein response of the endoplasmic reticulum in cisplatin-resistant A2780\/CisR ovarian cancer cells","volume":"53","author":"Jung","year":"2020","journal-title":"BMB Rep"},{"key":"10.1016\/j.jare.2026.02.012_b0050","article-title":"Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression","volume":"12","author":"Huang","year":"2025","journal-title":"Genes Dis"},{"key":"10.1016\/j.jare.2026.02.012_b0055","article-title":"The role of proteasomes in tumorigenesis","volume":"11","author":"Zhou","year":"2024","journal-title":"Genes Dis"},{"key":"10.1016\/j.jare.2026.02.012_b0060","first-page":"6316","article-title":"The proteasome as a target for cancer therapy","volume":"9","author":"Voorhees","year":"2003","journal-title":"Clin Can Res"},{"key":"10.1016\/j.jare.2026.02.012_b0065","first-page":"64","article-title":"The 26S proteasome complex: an attractive target for cancer therapy","volume":"2012","author":"Frankland-Searby","year":"1825","journal-title":"BBA"},{"key":"10.1016\/j.jare.2026.02.012_b0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14796694.1.2.161","article-title":"Bortezomib: proteasome inhibition as an effective anticancer therapy","volume":"1","author":"Richardson","year":"2005","journal-title":"Future Oncol"},{"key":"10.1016\/j.jare.2026.02.012_b0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2050-7771-1-13","article-title":"The resistance mechanisms of proteasome inhibitor bortezomib","volume":"1","author":"L\u00fc","year":"2013","journal-title":"Biomark Res"},{"key":"10.1016\/j.jare.2026.02.012_b0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/ph16010111","article-title":"Review on bortezomib resistance in multiple myeloma and potential role of emerging technologies","volume":"16","author":"Kozalak","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jare.2026.02.012_b0085","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.1016\/j.jmb.2017.09.015","article-title":"Meddling with fate: the proteasomal deubiquitinating enzymes","volume":"429","author":"de Poot","year":"2017","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jare.2026.02.012_b0090","doi-asserted-by":"crossref","first-page":"9830","DOI":"10.1074\/jbc.M116.763128","article-title":"The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis","volume":"292","author":"Kim","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2026.02.012_b0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13062-024-00588-6","article-title":"Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway","volume":"19","author":"Bao","year":"2024","journal-title":"Biol Direct"},{"key":"10.1016\/j.jare.2026.02.012_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.rechem.2024.101989","article-title":"An insight into the therapeutic impact of quinoxaline derivatives: recent advances in biological activities (2020\u20132024)","volume":"13","author":"Waseem","year":"2025","journal-title":"Results Chem"},{"key":"10.1016\/j.jare.2026.02.012_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116360","article-title":"Quinoxaline derivatives: recent discoveries and development strategies towards anticancer agents","volume":"271","author":"Montero","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jare.2026.02.012_b0110","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1021\/acs.bioconjchem.6b00305","article-title":"Identification of targets of the HIF-1 inhibitor IDF-11774 using alkyne-conjugated photoaffinity probes","volume":"27","author":"Ban","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.jare.2026.02.012_b0115","doi-asserted-by":"crossref","first-page":"10286","DOI":"10.1002\/anie.201304987","article-title":"Identification of malate dehydrogenase 2 as a target protein of the HIF-1 inhibitor LW6 using chemical probes","volume":"52","author":"Lee","year":"2013","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.jare.2026.02.012_b0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/prot.23147","article-title":"Structural characterization of human Uch37","volume":"80","author":"Burgie","year":"2012","journal-title":"Proteins"},{"key":"10.1016\/j.jare.2026.02.012_b0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.tem.2016.06.002","article-title":"Anticipatory UPR activation: a protective pathway and target in cancer","volume":"27","author":"Shapiro","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jare.2026.02.012_b0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41392-023-01570-w","article-title":"Endoplasmic reticulum stress: molecular mechanism and therapeutic targets","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jare.2026.02.012_b0135","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s12885-023-11317-z","article-title":"UCHL5 promotes hepatocellular carcinoma progression by promoting glycolysis through activating Wnt\/\u03b2-catenin pathway","volume":"24","author":"Wan","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jare.2026.02.012_b0140","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood-2013-05-500033","article-title":"A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance","volume":"123","author":"Tian","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jare.2026.02.012_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113402","article-title":"Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD)","volume":"421","author":"Yang","year":"2022","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jare.2026.02.012_b0150","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.7150\/jca.46146","article-title":"Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"key":"10.1016\/j.jare.2026.02.012_b0155","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1158\/0008-5472.CAN-10-1530","article-title":"Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis","volume":"70","author":"Kapuria","year":"2010","journal-title":"Can Res"},{"key":"10.1016\/j.jare.2026.02.012_b0160","doi-asserted-by":"crossref","first-page":"26979","DOI":"10.1038\/srep26979","article-title":"The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2026.02.012_b0165","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.jare.2026.02.012_b0170","first-page":"3302","article-title":"VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines","volume":"112","author":"Kurozumi","year":"2021","journal-title":"Can Sci"},{"key":"10.1016\/j.jare.2026.02.012_b0175","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2018.02.020","article-title":"Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt\/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells","volume":"825","author":"Ding","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2026.02.012_b0180","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3390\/ijms22126213","article-title":"Small-molecule inhibitors targeting proteasome-associated deubiquitinases","volume":"22","author":"Moon","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2026.02.012_b0185","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3390\/cancers12020265","article-title":"Proteasome inhibitors for the treatment of multiple myeloma","volume":"12","author":"Ito","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jare.2026.02.012_b0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/bloodadvances.2020003820","article-title":"Multiple myeloma cells depend on the DDI2\/NRF1-mediated proteasome stress response for survival","volume":"6","author":"Chen","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jare.2026.02.012_b0195","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fonc.2020.00802","article-title":"Actionable strategies to target multiple myeloma plasma cell resistance\/resilience to stress: insights from \u201comics\u201d research","volume":"10","author":"Manni","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jare.2026.02.012_b0200","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2007-08-104950","article-title":"Molecular basis of bortezomib resistance: proteasome subunit \u03b25 (PSMB5) gene mutation and overexpression of PSMB5 protein","volume":"112","author":"Oerlemans","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jare.2026.02.012_b0205","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1634\/theoncologist.2016-0104","article-title":"Analysis of real-world data on overall survival in multiple myeloma patients with \u22653 prior lines of therapy including a proteasome inhibitor (PI) and an immunomodulatory drug (IMiD), or double refractory to a PI and an IMiD","volume":"21","author":"Usmani","year":"2016","journal-title":"Oncologist"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226001438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123226001438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T03:48:03Z","timestamp":1785556083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123226001438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":41,"alternative-id":["S2090123226001438"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2026.02.012","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quinoxaline-based UCHL5 inhibitor as a next-generation proteasome-targeting anticancer agent beyond 20S inhibition","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}